Sovleplenib (HMPL-523) is a highly poten… and 2 more items

The University of Nebraska Medical Center (UNMC), a state agency located in Omaha, Nebraska, issued Purchase Order 4800191405 to MedChemExpress LLC on April 1, 2026, for the procurement of three pharmaceutical compounds totaling $337. The awarded contract encompasses Sovleplenib (HMPL-523) at $156 per unit, PRT062607 (P505-15) Hydrochloride at $156 per unit, and Cisplatin (CDDP) at $25 per unit, with one unit ordered for each compound. The place of performance is the UNMC facility located at 601 South Saddle Creek Road, Omaha, Nebraska, with delivery scheduled for April 15, 2026, under Free on Board (F.O.B.) destination terms with freight prepaid.

MedChemExpress LLC, based in Monmouth Junction, New Jersey, is the prime contractor for this purchase order. The contract period extends from April 1, 2026, to April 15, 2026, with payment terms established as Net 30. The vendor was required to acknowledge acceptance of the purchase order within ten days. The University of Nebraska, as a tax-exempt organization under exemption number 05-8905401, placed this order on behalf of the Board of Regents for use at the medical center facility.